Literature DB >> 28301655

Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.

Michele M Kim1, Rozhin Penjweini2, Timothy C Zhu2.   

Abstract

Existing dosimetric quantities do not fully account for the dynamic interactions between the key components of photodynamic therapy (PDT) or the varying PDT oxygen consumption rates for different fluence rates. Using a macroscopic model, reacted singlet oxygen ( [ O 2 1 ] rx ) was calculated and evaluated for its effectiveness as a dosimetric metric for PDT outcome. Mice bearing radiation-induced fibrosarcoma tumors were treated with benzoporphyrin derivative monoacid ring A (BPD) at a drug-light interval of 3 h with various in-air fluences (30 to 350 ?? J / cm 2 ) and in-air fluence rates (50 to 150 ?? mW / cm 2 ). Explicit measurements of BPD concentration and tissue optical properties were performed and used to calculate [ O 2 1 ] rx , photobleaching ratio, and PDT dose. For four mice, in situ measurements of O 2

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28301655      PMCID: PMC5301138          DOI: 10.1117/1.JBO.22.2.028002

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  26 in total

1.  An improved analytic function for predicting light fluence rate in circular fields on a semi-infinite geometry.

Authors:  Timothy C Zhu; Amy Lu; Yi-Hong Ong
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-03-07

2.  In-vivo singlet oxygen threshold doses for PDT.

Authors:  Timothy C Zhu; Michele M Kim; Xing Liang; Jarod C Finlay; Theresa M Busch
Journal:  Photonics Lasers Med       Date:  2015-02

Review 3.  Photodynamic therapy.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1993-12       Impact factor: 3.421

4.  Transport and accumulation of PVP-Hypericin in cancer and normal cells characterized by image correlation spectroscopy techniques.

Authors:  Rozhin Penjweini; Nick Smisdom; Sarah Deville; Marcel Ameloot
Journal:  Biochim Biophys Acta       Date:  2014-01-27

5.  Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.

Authors:  Ken Kang-Hsin Wang; Jarod C Finlay; Theresa M Busch; Stephen M Hahn; Timothy C Zhu
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

Review 6.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

7.  Modifying excitation light dose of novel photosensitizer PVP-Hypericin for photodynamic diagnosis and therapy.

Authors:  Rozhin Penjweini; Hans G Loew; Maria Eisenbauer; Karl W Kratky
Journal:  J Photochem Photobiol B       Date:  2013-01-10       Impact factor: 6.252

8.  Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.

Authors:  Rozhin Penjweini; Michele M Kim; Baochang Liu; Timothy C Zhu
Journal:  J Biophotonics       Date:  2016-09-22       Impact factor: 3.207

9.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

Authors:  K R Weishaupt; C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

Review 10.  Photodynamic therapy of cancer. Basic principles and applications.

Authors:  Angeles Juarranz; Pedro Jaén; Francisco Sanz-Rodríguez; Jesús Cuevas; Salvador González
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

View more
  7 in total

1.  Reactive Oxygen Species Explicit Dosimetry for Photofrin-mediated Pleural Photodynamic Therapy.

Authors:  Yi Hong Ong; Andreaa Dimofte; Michele M Kim; Jarod C Finlay; Tianqi Sheng; Sunil Singhal; Keith A Cengel; Arjun G Yodh; Theresa M Busch; Timothy C Zhu
Journal:  Photochem Photobiol       Date:  2019-12-06       Impact factor: 3.421

2.  Reactive oxygen species explicit dosimetry (ROSED) for fractionated photofrin-mediated photodynamic therapy (PDT).

Authors:  Hongjing Sun; Yi Hong Ong; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2022-03-04

3.  PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).

Authors:  Yi Hong Ong; Michele M Kim; Jarod C Finlay; Andreea Dimofte; Sunil Singhal; Eli Glatstein; Keith A Cengel; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2017-12-29       Impact factor: 3.609

4.  Reactive Oxygen Species Explicit Dosimetry (ROSED) of a Type 1 Photosensitizer.

Authors:  Yi Hong Ong; Michele M Kim; Zheng Huang; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2018-02

5.  Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice.

Authors:  Karl W Beeson; Evgueni Parilov; Mary Potasek; Michele M Kim; Timothy C Zhu
Journal:  J Biomed Opt       Date:  2019-03       Impact factor: 3.170

6.  Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.

Authors:  Tianqi Sheng; Yi Hong Ong; Wensheng Guo; Timothy Zhu
Journal:  J Biomed Opt       Date:  2020-01       Impact factor: 3.170

7.  Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment.

Authors:  Tobias J Moritz; Youbo Zhao; Michael F Hinds; Jason R Gunn; Jennifer R Shell; Brian W Pogue; Steven J Davis
Journal:  J Biomed Opt       Date:  2020-03       Impact factor: 3.170

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.